Investment Advisory Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.15M Buy
960
+52
+6% +$53.1K 0.25% 75
2026
Q1
$836K Buy
908
+34
+4% +$34.5K 0.21% 86
2025
Q4
$939K Buy
874
+8
+0.9% +$7.65K 0.24% 78
2025
Q3
$660K Sell
866
-1
-0.1% -$744 0.18% 92
2025
Q2
$676K Buy
867
+21
+2% +$16.3K 0.2% 88
2025
Q1
$698K Buy
846
+79
+10% +$65.7K 0.23% 85
2024
Q4
$592K Buy
767
+3
+0.4% +$2.48K 0.2% 89
2024
Q3
$677K Buy
764
+140
+22% +$126K 0.24% 82
2024
Q2
$565K Buy
624
+1
+0.2% +$800 0.22% 83
2024
Q1
$485K Buy
623
+9
+1% +$6.41K 0.2% 85
2023
Q4
$358K Sell
614
-11
-2% -$6.42K 0.16% 100
2023
Q3
$336K Buy
625
+19
+3% +$9.79K 0.17% 93
2023
Q2
$284K Buy
606
+12
+2% +$5.03K 0.15% 105
2023
Q1
$204K Hold
594
0.12% 131
2022
Q4
$217K Sell
594
-83
-12% -$29.4K 0.13% 125
2022
Q3
$219K Hold
677
0.15% 116
2022
Q2
$219K Buy
+677
New +$203K 0.15% 111

Other funds holding LLY

Investment Advisory Group's LLY Position: Q2 2026 in Review

Investment Advisory Group increased its Eli Lilly (LLY) stake by 5.7% in Q2 2026, buying an estimated $53.1K and bringing the position to 960 shares worth $1.15M. The position accounts for 0.25% of the portfolio, ranked #75.

Investment Advisory Group first reported a position in LLY in Q2 2022 and has held it in 17 quarters since. 4,633 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Investment Advisory Group held 960 shares of Eli Lilly worth $1.15M as of Q2 2026.
  • Investment Advisory Group bought 52 Eli Lilly shares in Q2 2026, an estimated $53.1K.
  • Eli Lilly made up 0.25% of Investment Advisory Group's portfolio in Q2 2026, its #75 holding.
  • Investment Advisory Group first reported a position in Eli Lilly in Q2 2022 and has held it in 17 quarters since.
  • 4,633 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Investment Advisory Group's 13F filing for Q2 2026, filed 6 Aug 2026.